SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-041875
Filing Date
2004-03-15
Accepted
2004-03-15 12:52:37
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 12/31/2003 d10k.htm 10-K 785580
3 SALES FORCE WORK ORDER dex1045.htm EX-10.45 132201
4 FORM OF INDEMNIFICATION dex1046.htm EX-10.46 44884
5 FORM OF EXECUTIVE CHANGE dex1047.htm EX-10.47 18386
6 CODE OF ETHICS dex14.htm EX-14 40553
7 SUBSIDIARIES dex21.htm EX-21 1020
8 CEO CERTIFICATION dex311.htm EX-31.1 6353
9 CFO CERTIFICATION dex312.htm EX-31.2 6362
10 SECTION 1350 CEO CERTIFICATION dex321.htm EX-32.1 3533
11 SECTION 1350 CFO CERTIFICATION dex322.htm EX-32.2 3542
  Complete submission text file 0001193125-04-041875.txt   1044966
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10352 | Film No.: 04668579
SIC: 2834 Pharmaceutical Preparations